These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25108533)

  • 61. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.
    Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P;
    Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Two cases of multidrug-resistant
    Poncin T; Merimeche M; Braille A; Mainardis M; Bebear C; Jacquier H; Berçot B
    Euro Surveill; 2019 Sep; 24(36):. PubMed ID: 31507264
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.
    Ison CA; Hussey J; Sankar KN; Evans J; Alexander S
    Euro Surveill; 2011 Apr; 16(14):. PubMed ID: 21492528
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High-level azithromycin-resistant Neisseria gonorrhoeae clinical isolate in France, March 2014.
    Bercot B; Belkacem A; Goubard A; Mougari F; Sednaoui P; La Ruche G; Cambau E
    Euro Surveill; 2014 Nov; 19(44):. PubMed ID: 25394255
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oral cefixime versus intramuscular ceftriaxone in patients with uncomplicated gonococcal infections.
    Portilla I; Lutz B; Montalvo M; Mogabgab WJ
    Sex Transm Dis; 1992; 19(2):94-8. PubMed ID: 1534422
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Challenges in implementing the new BASHH guidelines for the management of gonorrhoea.
    Rodgers S; Murgatroyd M; Perez K; Kingston M; Lee V
    Int J STD AIDS; 2014 Feb; 25(2):145-7. PubMed ID: 23970641
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Ross JDC; Brittain C; Cole M; Dewsnap C; Harding J; Hepburn T; Jackson L; Keogh M; Lawrence T; Montgomery AA; Roberts TE; Sprange K; Tan W; Thandi S; White J; Wilson J; Duley L;
    Lancet; 2019 Jun; 393(10190):2511-2520. PubMed ID: 31056291
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014-2016: focus on extended-spectrum cephalosporins and azithromycin.
    Ryan L; Golparian D; Fennelly N; Rose L; Walsh P; Lawlor B; Mac Aogáin M; Unemo M; Crowley B
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1661-1672. PubMed ID: 29882175
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Emergence and evolution of internationally disseminated cephalosporin-resistant Neisseria gonorrhoeae clones from 1995 to 2005 in Japan.
    Shimuta K; Watanabe Y; Nakayama S; Morita-Ishihara T; Kuroki T; Unemo M; Ohnishi M
    BMC Infect Dis; 2015 Sep; 15():378. PubMed ID: 26381611
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The incidence of gonorrhoea has dramatically increased in Sweden during the last 10 years].
    Nylander E; Unemo M
    Lakartidningen; 2021 Nov; 118():. PubMed ID: 34730833
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.
    Whiley DM; Trembizki E; Buckley C; Freeman K; Baird RW; Beaman M; Chen M; Donovan B; Kundu RL; Fairley CK; Guy R; Hogan T; Kaldor JM; Karimi M; Limnios A; Regan DG; Ryder N; Su JY; Ward J; Lahra MM
    Emerg Infect Dis; 2017 Sep; 23(9):1478-1485. PubMed ID: 28820128
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017.
    Lefebvre B; Martin I; Demczuk W; Deshaies L; Michaud S; Labbé AC; Beaudoin MC; Longtin J
    Emerg Infect Dis; 2018 Feb; 24(2):381-3. PubMed ID: 29131780
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae.
    Matsumoto T
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S35-9. PubMed ID: 18164598
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Australian Gonococcal Surveillance Programme, 1 April to 30 June 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2015 Dec; 39(4):E628-30. PubMed ID: 26779739
    [No Abstract]   [Full Text] [Related]  

  • 76. Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou, China (2009-2013): coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics.
    Liang JY; Cao WL; Li XD; Bi C; Yang RD; Liang YH; Li P; Ye XD; Chen XX; Zhang XB
    BMC Infect Dis; 2016 Apr; 16():152. PubMed ID: 27080231
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution.
    Wind CM; de Vries HJ; van Dam AP
    Int J Antimicrob Agents; 2015 Mar; 45(3):305-8. PubMed ID: 25532741
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gonorrhoea in 21st century--international and Polish situation.
    Serwin AB; Koper M; Unemo M
    Przegl Epidemiol; 2014; 68(1):39-44, 127-31. PubMed ID: 25004630
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management.
    Ison CA; Alexander S
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):867-76. PubMed ID: 21973299
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
    Tapsall JW
    Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.